J&J Ads Contain Misleading Safety Stats On Tremfya, Novartis Lawsuit Claims
Novartis has filed a lawsuit against Johnson & Johnson claiming it is using misleading advertising to promote the psoriasis drug Tremfya, which omits critical safety data.
Novartis has filed a lawsuit against Johnson & Johnson claiming it is using misleading advertising to promote the psoriasis drug Tremfya, which omits critical safety data.